GLAXO

HealthcareDrug Manufacturers - GeneralLarge Cap
GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) operates in the Healthcare sector, manufacturing, distributing, and trading pharmaceuticals in India and internationally. The compan...

हिन्दी में

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) हेल्थकेयर सेक्टर में काम करती है, जो भारत और अंतरराष्ट्रीय स्तर पर फार्मास्यूटिकल्स का निर्माण, वितरण और व्यापार करती है। कंपनी वयस्...

₹2,540.3+0.23%1D
Previous trading day close · Data updates after market close
1W: -7.0%
1M: -12.1%
6M: +5.2%
1Y: -7.3%
70/100
AverageResearch Score
Market Cap
₹40.1K Cr
Large Cap
P/E Ratio
39.17
Fair
P/B Ratio
17.90
Premium
ROE
49.1%
Strong
ROCE
55.4%
Excellent
Debt / Equity
0.01
Low debt
Div. Yield
2.4%
Good yield
EV/EBITDA
25.65
Expensive
52W Low: ₹2,088.1Current: ₹2,540.352W High: ₹3,120.7
At 44% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
94/100
Growth
Revenue, EPS, profit growth
71/100
Valuation
PE, PB, EV/EBITDA vs sector
27/100
Risk
Debt levels, volatility, coverage
89/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
39.17(Fair)
Forward P/E
35.02(Premium)
P/B Ratio
17.90(Premium)
P/S Ratio
10.18(Expensive)
EV/EBITDA
25.65(Expensive)
Dividend Yield
2.4%(Good yield)
5Y CAGR
9.6%(Moderate)
Revenue Growth
2.3%(Moderate)
Profitability
ROE
49.1%(Excellent)
ROCE
55.4%(Excellent)
ROA
24.6%(Efficient)
Net Margin
26.0%(High)
EBITDA Margin
37.0%
Financial Health
Debt to Equity
0.01(Low debt)
Current Ratio
2.03(Healthy)
Quick Ratio
1.77(Good)
Interest Coverage
516.03x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
25(Oversold)
RSI Exp (14)
22(Oversold)
MACD
-61.301(Bearish)
MACD Signal
-24.555
BB Position
-9%(Lower band)
BB Width
14.80%(Normal)
ADX (14)
18.8(Sideways)
Williams %R
-89.0(Oversold)
MFI (14)
60(Neutral)
CCI (20)
-237(Oversold)
Stoch %K
11(Oversold)
ATR (14)
85.91(Avg True Range)
OBV (M)
17.8(Positive)
1W OBV Chg
-0.7%(Decreasing)
Rel Volume
0.37x(Low activity)
Volatility
34.5%(Moderate)
Max DD 1Y
-39.3%(Moderate)
EMA 200
2606.5
EMA 50
2751.6
SMA 200
2509.9
vs SMA 50
-9.6%(Below SMA50)
vs SMA 200
1.2%(Above SMA200)
Volume
41.3K
Avg Vol 3M
1.1L
Shareholding Pattern
Promoter
75.0%
High confidence
FII
4.6%
DII / MF
7.7%
Share GLAXO
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.